CASK related movement disorder

Reading File

Finding Sources

The library doesn't contain dedicated sections on CASK-related movement disorders. I'll answer from established clinical and scientific knowledge.

CASK-Related Movement Disorders

CASK (Calcium/calmodulin-dependent serine protein kinase) encodes a membrane-associated guanylate kinase (MAGUK) scaffolding protein located at the X chromosome (Xp11.4). It is critical for synaptic organization, neurotransmission, and neuronal development.

Genetics

Feature	Detail
Gene	CASK (Xp11.4)
Inheritance	X-linked (predominantly de novo in females; loss-of-function in males is usually lethal)
Mutation types	Deletions, nonsense, missense, splice-site variants

Hemizygous males: Typically present with a severe, often lethal phenotype (MICPCH — see below), or a milder intellectual disability syndrome if hypomorphic alleles
Heterozygous females: Usually affected due to de novo mutations; present with a broad spectrum of severity

Primary Clinical Syndrome: MICPCH

Microcephaly with Pontine and Cerebellar Hypoplasia (MICPCH)

This is the hallmark neurological phenotype associated with loss-of-function CASK mutations, especially in females.

Core features:

Severe-to-profound intellectual disability
Progressive microcephaly (may be present at birth or develop postnatally)
Pontine and cerebellar hypoplasia on MRI — brainstem and cerebellum are underdeveloped
Hypotonia — universal and often the first presenting sign
Nystagmus — particularly downbeat or horizontal nystagmus, a consistent finding linked to cerebellar/brainstem pathology
Sensorineural hearing loss — frequent
Ophthalmologic abnormalities (optic atrophy, strabismus)
Absent or minimal speech
Feeding difficulties

Movement Disorder Components

The movement disorder in CASK-related disease arises from cerebellar hypoplasia, brainstem dysfunction, and disordered cortico-subcortical connectivity:

1. Ataxia

Cerebellar hypoplasia produces truncal and appendicular ataxia
Gait ataxia when ambulation is achieved
Dysmetria and intention tremor

2. Nystagmus

Downbeat nystagmus is the most characteristic ocular motor finding
Reflects vestibulocerebellum (flocculonodular lobe) hypoplasia
Can manifest as opsoclonus-like movements in some reports

3. Hyperkinetic movements

Stereotypies — repetitive, non-purposeful hand and limb movements
Dyskinesia — involuntary writhing movements, especially of the hands
Some patients exhibit choreoathetosis

4. Spasticity and dystonia

Upper motor neuron signs emerge in many patients
Dystonic posturing of hands and feet
Dystonia can be focal or generalized

5. Epilepsy with motor manifestations

Seizures (often infantile spasms or myoclonic seizures) contribute to the motor phenotype
EEG abnormalities are frequent

Milder Allelic Variants (Males)

Hypomorphic CASK mutations (partial loss-of-function) in males produce:

X-linked intellectual disability with or without nystagmus (XLID-nystagmus)
Less severe cerebellar involvement
Nystagmus, hypotonia, and cognitive impairment without full MICPCH
This phenotype overlaps with Oculomotor Apraxia in some kindreds

Pathophysiology

CASK interacts with:

Neurexins (presynaptic scaffold) — critical for synaptic vesicle release
CASK-TBRS complex (with TBR1) — regulates transcription of NMDAR subunit NR2b and other neuronal genes
Mint1/Lin7 — synaptic scaffolding at the active zone
β-neurexin/Mint1/CASK trimeric complex — disruption impairs GABAergic and glutamatergic transmission

Loss of CASK disrupts both synaptogenesis and transcriptional regulation of genes needed for pontocerebellar development, explaining the structural MRI findings and the resulting movement disorder.

Diagnostic Approach

MRI brain: Pontine and cerebellar hypoplasia ± simplified gyral pattern
Gene panel or exome sequencing: CASK sequencing with deletion/duplication analysis (chromosomal microarray)
Ophthalmologic evaluation: Nystagmus characterization
Audiology: Sensorineural hearing loss assessment
EEG: Seizure evaluation

Management

There is no disease-modifying treatment. Management is supportive:

Domain	Intervention
Spasticity/dystonia	Baclofen, benzodiazepines, botulinum toxin
Seizures	Anti-seizure medications (ACTH/vigabatrin for infantile spasms)
Nystagmus	Memantine or gabapentin (limited evidence)
Feeding	Gastrostomy if oral feeding is unsafe
Rehabilitation	PT, OT, speech therapy; augmentative communication
Hearing	Hearing aids or cochlear implant if eligible

Summary

CASK-related movement disorder is best understood as a cerebellar-brainstem syndrome driven by pontocerebellar hypoplasia. The key movement features are hypotonia, ataxia, nystagmus, dystonia/dyskinesia, and stereotypies — all occurring in the context of severe intellectual disability and microcephaly (MICPCH). The X-linked nystagmus syndrome in males represents the milder end of the same allelic spectrum.

This is a shared conversation. Sign in to Orris to start your own chat.